Answers are grounded in this paper and cite their sources.
An elderly woman with acquired haemophilia A secondary to a monoclonal gammopathy, required elective surgery for a parotid tumour but was unable to tolerate conventional treatment. Recombinant activated factor VII (rVIIa) was used successfully to cover a biopsy and then subsequent resection of the tumour. The use of rVIIa in the management of acquired inhibitors is discussed.
No takes yet. Share an insight, caveat, or question.
Doughty et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: